Compliance News | November 11, 2025 The administration, together with pharmaceutical manufacturers Eli Lilly and Novo Nordisk, announced an agreement to lower prices and expand access to glucagon-like peptide-1 receptor agonists (GLP-1s) for weight loss for those in the Medicare Part D and Medicaid programs as well as direct-to-consumer (DTC) purchasing
Factors such as dosage, treatment duration, and baseline vitamin D status significantly influence these variations
Our skin is an amazing barrier, and its incredibly difficult for such a large molecule to be absorbed effectively in sufficient quantities to have a therapeutic effect for weight loss, unlike the actual GLP-1 medications that are injected or specifically formulated for oral absorption
A weight trend view, not just a list of weigh-ins - the line matters more than the dots
Vitamin E Vitamin E supplements not only support your overall health but also benefit the skin tremendously